FDA Inspection
H. Henry Li, MDH. Henry Li, MD – FDA Inspection, Mar 24, 2023
Record Details
This FDA Inspection record concerns H. Henry Li, MD, with an inspection on March 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 48a3c6ac-6fb0-48b1-aeb8-7eaabe1322dc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1202279
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 50.55(e)(2)Two parents" permission: studies under Parts 50.53 - 50.54
- 21 CFR 50.55(e)(2)Two parents' permission: studies under Parts 50.53 - 50.54
Full citation text and observation details available on the Dashboard.
Other FDA inspections of H. Henry Li, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2016 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for H. Henry Li, MD
- FDA Inspection 991215 - 2016-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.